Cargando…

Effects of cancer stigma on quality of life of patients with hepatobiliary and pancreatic cancer

BACKGROUNDS/AIMS: Cancer stigma (CS), a self-inflicted sense of hopelessness, has been identified as a major factor affecting cancer patients’ outcomes. However, few studies have investigated the CS-related outcomes in hepatobiliary and pancreatic (HBP) cancer. Thus, the aim of this study was to inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Naru, Kang, Danbee, Shin, Sang Hyun, Heo, Jin Seok, Shim, Sungkeun, Lim, Jihyun, Cho, Juhee, Han, In Woong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Hepato-Biliary-Pancreatic Surgery 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201065/ https://www.ncbi.nlm.nih.gov/pubmed/36804208 http://dx.doi.org/10.14701/ahbps.22-084

Ejemplares similares

Systematic Review of Studies Assessing the Health-Related Quality of Life of Hepatocellular Carcinoma Patients from 2009 to 2018
por: Kang, Danbee, et al.
Publicado: (2020)

Validation of the Korean Version of the Patient-Reported Outcomes Measurement Information System 29 Profile V2.1 among Cancer Survivors
por: Kang, Danbee, et al.
Publicado: (2022)

National survey of Korean hepatobiliary-pancreatic surgeons on attitudes about the enhanced recovery after surgery protocol
por: Shin, Sang Hyun, et al.
Publicado: (2020)

Fear of Cancer Recurrence and Its Negative Impact on Health-Related Quality of Life in Long-term Breast Cancer Survivors
por: Tran, Thi Xuan Mai, et al.
Publicado: (2022)

Psychometric validation of the Korean version of PROMIS 29 Profile V2.1 among patients with lower extremity problems
por: Kim, Youngha, et al.
Publicado: (2021)

Psychometric validation of the Korean Patient-Reported Outcome Measurement Information System (PROMIS)-29 Profile V2.1 among patients with chronic pulmonary diseases
por: Kang, Danbee, et al.
Publicado: (2021)

Validation of Korean Version of the COmprehensive Score for Financial Toxicity (COST) among Breast Cancer Survivors
por: Shim, Sungkeun, et al.
Publicado: (2022)

The difference in knowledge and attitudes of using mobile health applications between actual user and non-user among adults aged 50 and older
por: Lee, Mangyeong, et al.
Publicado: (2020)

Hereditary Pancreatic and Hepatobiliary Cancers
por: Haddad, Ashraf, et al.
Publicado: (2011)

Psychometric Validation of the Korean Version of the Cancer Survivors’ Unmet Needs (CaSUN) Scale among Korean Non–Small Cell Lung Cancer Survivors
por: Kang, Danbee, et al.
Publicado: (2023)

MicroRNAs in Hepatobiliary and Pancreatic Cancers
por: Saito, Yoshimasa, et al.
Publicado: (2011)

Predictive Nomogram for Early Recurrence after Pancreatectomy in Resectable Pancreatic Cancer: Risk Classification Using Preoperative Clinicopathologic Factors
por: Kim, Naru, et al.
Publicado: (2020)

Validation of the Korean Version of the Quality of Life–Cancer Survivors (QOL-CS-K) Questionnaire in Lymphoma Survivors
por: Cho, Juhee, et al.
Publicado: (2018)

Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers
por: Hochnadel, Inga, et al.
Publicado: (2017)

Trend Analysis and Prediction of Hepatobiliary Pancreatic Cancer Incidence and Mortality in Korea
por: Park, Hyeong Min, et al.
Publicado: (2022)

Hepatobiliary and pancreatic ascariasis
por: Khuroo, Mohammad S, et al.
Publicado: (2016)

Validation of original and alternative fistula risk scores in postoperative pancreatic fistula
por: Ryu, Youngju, et al.
Publicado: (2019)

Clinical outcomes of pancreaticoduodenectomy for pancreatic ductal adenocarcinoma depending on preservation or resection of pylorus
por: Kim, Yeon Jin, et al.
Publicado: (2020)

Gallstones, Cholecystectomy and the Risk of Hepatobiliary and Pancreatic Cancer: A Nationwide Population-based Cohort Study in Korea
por: Huang, Dan, et al.
Publicado: (2020)

RON in hepatobiliary and pancreatic cancers: Pathogenesis and potential therapeutic targets
por: Chen, Shao-Long, et al.
Publicado: (2021)

Racial differences in long-term social, physical, and psychological health among adolescent and young adult cancer survivors
por: Kim, Sooyeon, et al.
Publicado: (2023)

The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry
por: Satake, Tomoyuki, et al.
Publicado: (2022)

A return-to-work intervention protocol directed at cancer patients (self-assessment, tailored information & lifestyle management for returning to work among cancer patients, START): A multi-center, randomized controlled trial
por: Bae, Ka Ryeong, et al.
Publicado: (2020)

Longitudinal changes in pulmonary function and patient-reported outcomes after lung cancer surgery
por: Shin, Sumin, et al.
Publicado: (2022)

Pathological Response Predicts Survival after Pancreatectomy following Neoadjuvant FOLFIRINOX for Pancreatic Cancer
por: Jeon, Hyun Jeong, et al.
Publicado: (2022)

Textbook outcomes in hepatobiliary and pancreatic surgery
por: Tsilimigras, Diamantis I, et al.
Publicado: (2021)

Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers
por: Marin, Jose J. G., et al.
Publicado: (2022)

Special Issue “Hepatobiliary and Pancreatic Cancers: Novel Strategies for of Diagnosis and Treatments”
por: Coppola, Alessandro, et al.
Publicado: (2022)

Precision Medicine of Hepatobiliary and Pancreatic Cancers: Focusing on Clinical Trial Outcomes
por: Tsumura, Takehiko, et al.
Publicado: (2022)

Development of Nomograms for Predicting Prognosis of Pancreatic Cancer after Pancreatectomy: A Multicenter Study
por: Yoon, So Jeong, et al.
Publicado: (2022)

Health-Related Quality of Life in Non-Hodgkin Lymphoma Survivors: A Prospective Cohort Study
por: Kang, Danbee, et al.
Publicado: (2018)

Survival Benefit after Shifting from Upfront Surgery to Neoadjuvant Treatment in Borderline Resectable Pancreatic Cancer
por: Jeon, Hyun Jeong, et al.
Publicado: (2023)

Follow-up results of acute portal and splenic vein thrombosis with or without anticoagulation therapy after hepatobiliary and pancreatic surgery
por: Cho, Chan Woo, et al.
Publicado: (2015)

Comprehensive molecular profiling to predict clinical outcomes in pancreatic cancer
por: Hong, Jung Yong, et al.
Publicado: (2021)

Correction: The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry
por: Satake, Tomoyuki, et al.
Publicado: (2022)

Unmet Supportive Care Needs after Non-Small Cell Lung Cancer Resection at a Tertiary Hospital in Seoul, South Korea
por: Park, Junhee, et al.
Publicado: (2023)

Effectiveness of Self-Assessment, TAilored Information, and Lifestyle Management for Cancer Patients’ Returning to Work (START): A Multi-center, Randomized Controlled Trial
por: Kang, Danbee, et al.
Publicado: (2023)

The outcome of endoscopic management of bile leakage after hepatobiliary surgery
por: Yun, Seon Ung, et al.
Publicado: (2017)

Associations between serum uric acid and hepatobiliary-pancreatic cancer: A cohort study
por: Huang, Chong-Fei, et al.
Publicado: (2020)

The State of Immunotherapy in Hepatobiliary Cancers
por: Ilyas, Farhan Z., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_am2pnmf22f0fp1nhvf6cvo96aq